Center for Scientific Review; Notice of Closed Meetings, 87883-87884 [2024-25651]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 214 / Tuesday, November 5, 2024 / Notices
designated, the name of the service area,
population group, or facility involved is
listed under the county name. A county
that has a whole county geographic or
population group HPSA is indicated by
the phrase ‘‘County’’ following the
county name.
ddrumheller on DSK120RN23PROD with NOTICES1
Development of the Designation and
Withdrawal Lists
HRSA continuously receives requests
for designation or withdrawal of a
particular geographic area, population
group, or facility as a HPSA. Under a
Cooperative Agreement between HRSA
and the 54 state and territorial primary
care offices (PCOs), PCOs conduct needs
assessments and submit applications to
HRSA to designate HPSAs. HRSA refers
requests that come from other sources to
PCOs for review. In addition, interested
parties, including governors, state
primary care associations, and state
professional associations, are notified of
requests so that they may submit their
comments and recommendations.
HRSA reviews each recommendation
for possible addition, continuation,
revision, or withdrawal. Following
review, HRSA notifies the appropriate
agency, individuals, and interested
organizations of each designation of a
HPSA, rejection of recommendation for
HPSA designation, revision of a HPSA
designation, and/or advance notice of
pending withdrawals from the HPSA
list. Designations (or revisions of
designations) are effective as of the date
on the notification from HRSA and are
updated daily on the HRSA Data
Warehouse website. The effective date
of a withdrawal will be the next
publication of a notice regarding the list
of designated HPSAs in the Federal
Register.
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Date: December 4, 2024.
Time: 10:15 a.m. to 4:00 p.m. Eastern Time
(ET).
Agenda: Interagency Pain Research
Coordinating Committee member updates
and other committee business, including
Federal Pain Research Strategy research
progress, communication and dissemination
strategies, and workgroup updates.
Webcast Live: https://videocast.nih.gov/.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Leah Pogorzala, Ph.D.,
Policy Analyst, Office of Pain Policy and
Planning, Office of the Director, National
Institute of Neurological Disorders and
Stroke, NIH, Bethesda, MD 20892, Phone:
(301) 496–4228, Email: leah.pogorzala@
nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Written comments should be submitted
to the contact person by 5:00 p.m. ET on
November 27, 2024.
Information is also available on the
IPRCC website https://iprcc.nih.gov,
where an agenda and any additional
information for the meeting will be
posted when available.
Diana Espinosa,
Principal Deputy Administrator.
Dated: October 30, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–25624 Filed 11–4–24; 8:45 am]
[FR Doc. 2024–25650 Filed 11–4–24; 8:45 am]
BILLING CODE 4165–15–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Pain
Research Coordinating Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following Meetings.
The Meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
18:07 Nov 04, 2024
Jkt 265001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
87883
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Developmental Biology.
Date: December 2, 2024.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Anne Marie Strohecker,
Ph.D., Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 867–5309,
stroheckeram@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Health Services and Systems B.
Date: December 3–4, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tara Roshell Earl, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C,
Bethesda, MD 20892, (301) 402–6857, earltr@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Microbial Diagnostics, Detection
and Decontamination.
Date: December 3–4, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Special topics in Mechanistic and
Clinical Neuroscience.
Date: December 3, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, (301) 435–
1259, nadis@csr.nih.gov.
E:\FR\FM\05NON1.SGM
05NON1
87884
Federal Register / Vol. 89, No. 214 / Tuesday, November 5, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
122: Research with Activities Related to
Diversity (ReWARD).
Date: December 3–4, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Katherine M. Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, (301) 435–
0912, malindakm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Autoimmune Arthritis.
Date: December 3, 2024.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4203,
Bethesda, MD 20892, (301) 435–3566,
mulkya@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
22–034: HEAL Initiative.
Date: December 3, 2024.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Roger Janz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8515, janzr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–25651 Filed 11–4–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative and
Innovative Acceleration Award (CCIA)
Review.
Date: February 20, 2025.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, 9609 Medical Center Drive,
Rockville, MD 20892 (Virtual).
Contact Person: Jing Chen, Ph.D., Scientific
Review Officer, Office of Scientific Review,
National Center for Advancing Translational
Sciences, National Institutes of Health, 9609
Medical Center Drive, Suite 1E504, Bethesda,
MD 20892, (301) 827–3268, chenjing@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: October 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–25649 Filed 11–4–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
18:07 Nov 04, 2024
Jkt 265001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Research Grants in Vascular Biology
and Hematology.
Date: December 3, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Courtney Elaine Watkins,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–3093, email:
courtney.watkins2@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Native
American Research Centers for Health
(NARCH) and NARCH Planning Grants.
Date: December 3–4, 2024.
Time: 11:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Heidi B. Friedman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 907–H,
Bethesda, MD 20892, (301) 379–5632, email:
hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurodegeneration, Cell death, and
Mitochondrial function.
Date: December 4, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Christine Jean DiDonato,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1014J,
Bethesda, MD 20892, (301) 435–1042, email:
didonatocj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR23–138:
Instrumentation Grant Program for ResourceLimited Institutions (S10).
Date: December 4, 2024.
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 89, Number 214 (Tuesday, November 5, 2024)]
[Notices]
[Pages 87883-87884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25651]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following Meetings.
The Meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Developmental Biology.
Date: December 2, 2024.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Anne Marie Strohecker, Ph.D., Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 867-5309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Health Services and Systems B.
Date: December 3-4, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tara Roshell Earl, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C, Bethesda, MD 20892, (301)
402-6857, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Microbial Diagnostics, Detection and
Decontamination.
Date: December 3-4, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Shinako Takada, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-5997,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Special topics in Mechanistic and Clinical
Neuroscience.
Date: December 3, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, (301)
435-1259, [email protected].
[[Page 87884]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-23-122: Research with Activities Related to Diversity
(ReWARD).
Date: December 3-4, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Katherine M. Malinda, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD
20892, (301) 435-0912, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Autoimmune Arthritis.
Date: December 3, 2024.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Alok Mulky, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4203, Bethesda, MD 20892, (301) 435-3566,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-22-034: HEAL Initiative.
Date: December 3, 2024.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Roger Janz, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-25651 Filed 11-4-24; 8:45 am]
BILLING CODE 4140-01-P
